GERM
GERM
About ETFMG Treatments, Testing and Advancements ETF
The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities...
About ETFMG Treatments, Testing and Advancements ETF
The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 ALNY | Alnylam Pharmaceuticals, Inc. | 11.39% | 3.96K | $1.07M |
 LH | Labcorp Holdings Inc. | 7.20% | 2.98K | $674.40K |
 DGX | Quest Diagnostics Incorporated | 6.61% | 4.14K | $618.44K |
 BNTX | BioNTech SE | 5.01% | 5.80K | $468.88K |
 BIO | Bio-Rad Laboratories, Inc. | 4.74% | 1.36K | $443.37K |
 PCVX | Vaxcyte, Inc. | 4.52% | 5.43K | $423.10K |
 QDEL | QuidelOrtho Corporation | 4.11% | 9.25K | $384.99K |
 BCRX | BioCryst Pharmaceuticals, Inc. | 3.70% | 45.43K | $346.60K |
 IMCR | Immunocore Holdings plc | 3.67% | 9.23K | $343.21K |
 ZLAB | Zai Lab Limited | 3.60% | 20.73K | $337.05K |
 MRNA | Moderna, Inc. | 3.46% | 3.82K | $324.35K |
 DVAX | Dynavax Technologies Corporation | 3.42% | 28.81K | $319.80K |
 IBRX | ImmunityBio, Inc. | 3.14% | 64.67K | $293.61K |
 VIR | Vir Biotechnology, Inc. | 2.79% | 29.95K | $260.85K |
 NVAX | Novavax, Inc. | 2.50% | 20.14K | $233.63K |
 OPK | OPKO Health, Inc. | 2.46% | 153.42K | $230.12K |
 CVAC | CureVac N.V. | 1.73% | 49.37K | $161.94K |
 FLGT | Fulgent Genetics, Inc. | 1.68% | 6.59K | $157.56K |
 ABUS | Arbutus Biopharma Corporation | 1.62% | 41.54K | $151.62K |
 ADPT | Adaptive Biotechnologies Corporation | 1.55% | 32.44K | $145.00K |
SECTOR HOLDINGS
Healthcare
Cash & Others
Financial ServicesASSET ALLOCATION BY REGION
United States
Germany
United Kingdom
China
France
JapanSECTOR HOLDINGS
Healthcare Cash & Others Financial ServicesASSET ALLOCATION BY REGION
United States Germany United Kingdom China France JapanHoldings (Top 20)
ALNY
Alnylam Pharmaceuticals, Inc.
LH
Labcorp Holdings Inc.
DGX
Quest Diagnostics Incorporated
BNTX
BioNTech SE
BIO
Bio-Rad Laboratories, Inc.
PCVX
Vaxcyte, Inc.
QDEL
QuidelOrtho Corporation
BCRX
BioCryst Pharmaceuticals, Inc.
IMCR
Immunocore Holdings plc
ZLAB
Zai Lab Limited
MRNA
Moderna, Inc.
DVAX
Dynavax Technologies Corporation
IBRX
ImmunityBio, Inc.
VIR
Vir Biotechnology, Inc.
NVAX
Novavax, Inc.
OPK
OPKO Health, Inc.
CVAC
CureVac N.V.
FLGT
Fulgent Genetics, Inc.
ABUS
Arbutus Biopharma Corporation
ADPT
Adaptive Biotechnologies Corporation